Clinical Trials Browser

INDUSTRY × Lymphoma, Mantle-Cell × enzastaurin × Clear all

NCT00088205 2020-07-01

Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma

Phase 2 Completed

60 enrolled 17 charts

Lymphoma, Mantle-Cell